Although we detected an increase in the amount of total immunostaining of PIEZO1 in VAT biopsies obtained from patients with obesity and T2D compared to that of volunteers with NW and with obesity and NG, differences were not statistically significant (Fig. 1D). Here, PIEZO1 is linked to obesity disorder.